BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 27045515)

  • 1. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases.
    Sharma R; Wang Y; Chen L; Gurda GT; Geddes S; Gabrielson E; Askin F; Li QK
    Hum Pathol; 2016 Aug; 54():8-16. PubMed ID: 27045515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases.
    Gurda GT; Zhang L; Wang Y; Chen L; Geddes S; Cho WC; Askin F; Gabrielson E; Li QK
    Clin Transl Med; 2015; 4():16. PubMed ID: 25977750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis.
    Kadota K; Nitadori J; Rekhtman N; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2015 Sep; 39(9):1170-80. PubMed ID: 25871623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-small cell lung carcinoma with focal coexpression of thyroid transcription factor-1 and Δ Np63/p40: A case report.
    Terada K; Menju T; Date H; Haga H; Yoshizawa A
    Thorac Cancer; 2024 Apr; 15(12):1029-1033. PubMed ID: 38478955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrepancies Between Morphological and Immunohistochemical Classifications Are Associated With Prognoses and Subtypes of Lung Cancer.
    Natsume K; Ye J; Mukai Y; Yamakawa K; Tanimoto M; Ito H; Miyagi Y; Daigo Y; Muto-Ishizuka M; Kadota K; Haba R; Suizu F
    Anticancer Res; 2024 Feb; 44(2):711-722. PubMed ID: 38307593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.
    Rekhtman N; Pietanza CM; Sabari J; Montecalvo J; Wang H; Habeeb O; Kadota K; Adusumilli P; Rudin CM; Ladanyi M; Travis WD; Joubert P
    Mod Pathol; 2018 Jan; 31(1):111-121. PubMed ID: 28884744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-small cell lung carcinomas with diffuse coexpression of TTF1 and p40: clinicopathological and genomic features of 14 rare biphenotypic tumours.
    Savari O; Febres-Aldana C; Chang JC; Fanaroff RE; Ventura K; Bodd F; Paik P; Vundavalli M; Saqi A; Askin FB; Travis WD; Rekhtman N
    Histopathology; 2023 Jan; 82(2):242-253. PubMed ID: 36130728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary metastasis of a papillary thyroid carcinoma and primary lung adenocarcinoma: two coincident carcinomas at the same location.
    Xue L; Luan Z; Liu Y; Zou S; Jiang J; Wu N; Lu N; Lin D
    Diagn Pathol; 2013 Feb; 8():26. PubMed ID: 23414265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical Evaluation of TTF-1, Napsin-A, and p-63 for Subtyping of Non-Small Cell Lung Carcinoma and Clinicopathological Correlation.
    Sharma T; Das P; Panigrahi R; Rao CM; Rath J
    J Cytol; 2022; 39(4):180-187. PubMed ID: 36605876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of transcript factors SALL4 and OCT4 in a subset of non-small cell lung carcinomas (NSCLC).
    Rodriguez E; Chen L; Ao MH; Geddes S; Gabrielson E; Askin F; Zhang H; Li QK
    Transl Respir Med; 2014 Dec; 2(1):10. PubMed ID: 25346886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Immunoreactivity with TTF-1 Antibodies 8G7G3/1 and SPT24 Suggest Distinct Immunoprofiles Between Most Pulmonary and Nonpulmonary Small Cell Carcinomas.
    Briski LM; Aron M; Epstein JI; Russell DH; Assarzadegan N; Delma KS; O'Dell H; Rodriguez E; Montgomery EA; Kryvenko ON
    Int J Surg Pathol; 2024 Apr; 32(2):230-238. PubMed ID: 37170625
    [No Abstract]   [Full Text] [Related]  

  • 12. Biphenotypic lung carcinoma with coexpression of TTF-1 and ΔNP63/P40 within most of the same individual cells: a further case confirming poor prognosis and a review of literature.
    Marando A; Zagni M; Negrelli M; Valtorta E; Lauricella C; Motta V; Veronese S; Cerea G; Giannetta LG; Ciarlo G; Signorelli D; Pizzutilo EG; Bonoldi E; Pelosi G
    Pathologica; 2024 Feb; 116(1):13-21. PubMed ID: 38482671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse coexpression of thyroid transcription factor-1 and p40 in a non-small cell carcinoma of the lung: Second case in the female population.
    Segado Martínez M; Ruiz García G
    Rev Esp Patol; 2024; 57(2):120-122. PubMed ID: 38599731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and immunohistochemical profile of non-small cell lung carcinoma in a tertiary care medical centre in South India.
    Shankar S; Thanasekaran V; Dhanasekar T; Duvooru P
    Lung India; 2014 Jan; 31(1):23-8. PubMed ID: 24669077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of imbalance between the master regulators TTF1/NKX2-1 and ΔNp63/p40 implies adverse prognosis in non-small cell lung cancer.
    Vescio M; Bulloni M; Pelosi G; Pattini L
    Sci Rep; 2024 Jan; 14(1):2467. PubMed ID: 38291083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of napsin A-positive metastatic lung cancer originating from the colon.
    Ito T; Nakanishi K; Goto H
    Surg Case Rep; 2017 Nov; 3(1):114. PubMed ID: 29124480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological analysis of bronchiolar adenoma combined with lung adenocarcinoma: Report of eight cases and literature review.
    Zhu M; Yang Q; Zhan S; Liu W; Liu W; Guo L; Huang S
    Histol Histopathol; 2024 Jun; 39(6):783-794. PubMed ID: 38059279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRPS1 function beyond breast: A retrospective immunohistochemical study on non-breast cytology specimens.
    Ali A; Geetha S; Wu D; Chau K; Karam P; Khutti S; Fayyaz SS; Das K; Gimenez C; Rosca OC
    Diagn Cytopathol; 2024 May; ():. PubMed ID: 38794964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral type squamous cell carcinoma of the lung: clinicopathologic characteristics in comparison to the central type.
    Sung YE; Cho U; Lee KY
    J Pathol Transl Med; 2020 Jul; 54(4):290-299. PubMed ID: 32544984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of dual-marker staining to differentiate between lung squamous cell carcinoma and adenocarcinoma.
    Guo R; Tian Y; Zhang N; Huang H; Huang Y; Yang J
    J Int Med Res; 2020 Apr; 48(4):300060519893867. PubMed ID: 31880186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.